Praxsyn (Praxsyn) Pre-Tax Income : $12.22 Mil (TTM As of Sep. 2015)

View and export this data going back to 2007. Start your Free Trial

What is Praxsyn Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Praxsyn's pretax income for the three months ended in Sep. 2015 was $5.61 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2015 was $12.22 Mil. Praxsyn's pretax margin was 27.47%.

Praxsyn Pre-Tax Income Historical Data

The historical data trend for Praxsyn's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn Pre-Tax Income Chart

Praxsyn Annual Data

Trend

Oct05

Oct06

Oct07

Oct08

Oct09

Dec10

Dec11

Dec12

Dec13

Dec14

Pre-Tax Income

Get a 7-Day Free Trial

-4.06

-7.51

-0.88

0.77

-12.57

Praxsyn Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Pre-Tax Income	Get a 7-Day Free Trial															0.45	-0.23	1.28	5.55	5.61

Competitive Comparison of Praxsyn's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Praxsyn's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Praxsyn's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Praxsyn's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Praxsyn's Pre-Tax Income falls into.

Praxsyn Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Praxsyn's Pretax Income for the fiscal year that ended in Dec. 2014 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	26.066	+	-6.902	+	-31.733	+	0	+	0.001000000000003
	=	-12.57

Praxsyn's Pretax Income for the quarter that ended in Sep. 2015 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	5.406	+	0.399	+	-0.193	+	0	+	-0.0010000000000003
	=	5.61

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.22 Mil.

Praxsyn (GREY:PXYN) Pre-Tax Income Explanation

Praxsyn's Pretax Margin for the quarter that ended in Sep. 2015 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	5.611	/	20.429
	=	27.47%

Praxsyn Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Praxsyn's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Praxsyn (Praxsyn) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101

Website

http://www.praxsyncorp.com

Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.